Homeless people in the county of Phoenix, Arizona, made up 130 of the 339 who died of heat-associated causes in 2021; patients who are addicted to opioids may lose online help if federal regulations expire; Paul M Ellwood Jr, MD, the creator of the health maintenance organization (HMO) concept, died aged 95 years.
Homeless in Phoenix Suffer in Extreme Heat
The homeless population of Phoenix, Arizona, and the surrounding towns in the county made up 130 of the 339 deaths who had died from heat-associated causes in 2021, according to AP News. Excessive heat has caused more weather-related deaths in the United States than hurricanes, flooding, and tornadoes combined. An analysis also found that exposure to extreme heat now affects almost a quarter of the world’s population, making it a worldwide problem mostly related to climate change. Phoenix has recently opened a 200-bed shelter for homeless people to combat excessive heat deaths in the homeless population.
Patients Addicted to Opioids May Lose Virtual Care
Federal regulations that have allowed the prescription of buprenorphine over audio or video appointments are set to expire along with the COVID-19 public health emergency, even as opioid deaths are reaching record highs. Politico reported that the deadline could come as soon as October, as the Drug Enforcement Agency has missed deadlines to continue virtual access. The expiration of these regulations could be a blow to the fight against opioid addiction in young adults. There are currently more people who die of drug overdose than guns or suicide, according to CDC data.
Paul M Ellwood Jr, MD, Dead Aged 95
Paul M Ellwood Jr, MD, died on Monday, June 20, aged 95 years. Ellwood is credited with conceiving and implementing the term health maintenance organization (HMO) in which doctors are paid by number of patients seen and whose enrolled members are guaranteed access to network doctors and care for fixed premiums. HMOs claim to offer high-quality service and cut overlapping medical consultations, unnecessary treatments, and unnecessary hospitalizations. Critics of the HMO claim that prepaid plans run the risk of skimpy care. Ellwood died of organ failure at a care center, according to his wife.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Evolving Roles of Antibody-Drug Conjugates in the Treatment of NSCLC
September 7th 2025Antibody-drug conjugates are rapidly reshaping the treatment landscape of non–small cell lung cancer (NSCLC), with advances in design, clinical efficacy, and regulatory approvals tempered by ongoing challenges in toxicity, resistance, and biomarker optimization.
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Comparing Global Standards in Lung Cancer: NCCN, ESMO, and CHEST Guidelines
September 6th 2025National Comprehensive Cancer Network (NCCN), the European Society for Medical Oncology (ESMO), and the American College of Chest Physicians (CHEST) offer complementary yet distinct frameworks for lung cancer care, reflecting differences in evidence evaluation, regional adaptation, and policy integration.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More